{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Jeremy+Lefroy&answer.answeringMemberConstituency=Winchester&hansardHeading=Medical+Treatments%3A+Innovation", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Jeremy+Lefroy&answer.answeringMemberConstituency=Winchester&hansardHeading=Medical+Treatments%3A+Innovation", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Jeremy+Lefroy&answer.answeringMemberConstituency=Winchester&_metadata=all&hansardHeading=Medical+Treatments%3A+Innovation", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Jeremy+Lefroy&_page=0&answer.answeringMemberConstituency=Winchester&hansardHeading=Medical+Treatments%3A+Innovation", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Jeremy+Lefroy&answer.answeringMemberConstituency=Winchester&hansardHeading=Medical+Treatments%3A+Innovation", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Jeremy+Lefroy&answer.answeringMemberConstituency=Winchester&hansardHeading=Medical+Treatments%3A+Innovation", "items" : [{"_about" : "http://data.parliament.uk/resources/964649", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/964649/answer", "answerText" : {"_value" : "

The Accelerated Access Collaborative (AAC) has been successfully established, meeting for the first time in January 2018 and agreeing terms of reference and ways of working. Lord Darzi is the new chair of the AAC, replacing Sir Andrew Witty, who stood down to avoid any conflict of interest with his new role as CEO of Optum. We expect that the Accelerated Access Pathway will launch at the next meeting of the AAC, which will be in the autumn.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-09-11", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-09-11T14:37:19.627Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-09-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medical Treatments: Innovation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what progress his Department has made on establishing an Accelerated Access Collaborative to manage the new accelerated access pathway.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4109", "label" : {"_value" : "Biography information for Jeremy Lefroy"} } , "tablingMemberConstituency" : {"_value" : "Stafford"} , "tablingMemberPrinted" : [{"_value" : "Jeremy Lefroy"} ], "uin" : "169360"} , {"_about" : "http://data.parliament.uk/resources/964650", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/964650/answer", "answerText" : {"_value" : "

The Accelerated Access Collaborative will meet this autumn to launch the Accelerated Access Pathway and the first group of products will be part of their discussions.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-09-11", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-09-11T14:35:39.31Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-09-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medical Treatments: Innovation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, when the accelerated access pathway is planned to begin designating breakthrough products.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4109", "label" : {"_value" : "Biography information for Jeremy Lefroy"} } , "tablingMemberConstituency" : {"_value" : "Stafford"} , "tablingMemberPrinted" : [{"_value" : "Jeremy Lefroy"} ], "uin" : "169361"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }